[Federal Register Volume 63, Number 58 (Thursday, March 26, 1998)]
[Notices]
[Page 14719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-7895]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee for Reproductive Health Drugs; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Advisory Committee for Reproductive Health 
Drugs.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on April 20, 1998, 8:30 
a.m. to 5 p.m.
    Location: Holiday Inn, Ballrooms I, II, III, and IV, Two Montgomery 
Village Ave., Gaithersburg, MD.
    Contact Person: Kimberly L. Topper or Robin M. Spencer, Center for 
Drug Evaluation and Research (HFD-21), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857-1000, 301-443-5455, or e-mail 
[email protected], or FDA Advisory Committee Information Line, 1-
800-741-8138 (301-443-0572 in the Washington, DC area), code 12537. 
Please call the Information Line for up-to-date information on this 
meeting.
    Agenda: The committee will discuss new drug application (NDA) 20-
797, Antocin (atosiban injection, R. W. Johnson) for use in the 
management of premature labor.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by April 10, 
1998. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before April 10, 1998, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 19, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-7895 Filed 3-25-98; 8:45 am]
BILLING CODE 4160-01-F